Figure 2
Proportion of clinical outcomes for 103 participants with moderate-severe COVID-19 randomized to treatment with convalescent plasma versus placebo at day 28 post recruitment.
Figure 2 | Scientific Reports
Proportion of clinical outcomes for 103 participants with moderate-severe COVID-19 randomized to treatment with convalescent plasma versus placebo at day 28 post recruitment.
